There's a reason why I would hold these shares for the long term. The post 3 ASX shares I would hold for the next 10 years ...

Cochlear Limited, which creates implantable hearing devices, has taken a technological leap forward with a device that syncs up with various Apple products. The Nucleus 7 Sound Processor, which was ...

Cochlear Limited, a medical device company specializing in implantable hearing solutions, is launching two new bone conduction sound processor devices for patients with high levels of hearing loss.

Cochlear, the global leader in implantable hearing solutions, is proud to announce that the groundbreaking Nucleus® Nexa® ...

LONE TREE, Colo., May 3, 2021 /PRNewswire/ -- Adults with cochlear implants may be able to improve their listening and communications skills in daily life with the help of a new self-guided digital ...

In a report released today, Sean Laaman from Morgan Stanley maintained a Hold rating on Cochlear Limited (CHEOF – Research Report), with a price target of A$240.00. The company’s shares closed ...

Cochlear Limited (AU:COH) has released an update. Cochlear Limited recently reported changes in the interests of its director, Diggory William Howitt, involving the acquisition of 11,000 shares and ...

Cochlear Limited (AU:COH) has released an update. Cochlear Limited has announced a continuation of its share buy-back program, purchasing 2,500 shares on the previous day, adding to the 44,500 already ...

Using visual support technology powered by TechSee, Cochlear has been able to bolster their customer experience by focusing on the needs of recipients through the use of Augmented Reality. NEW YORK, ...

Thank you for standing by, and welcome to the Cochlear Limited Half Year 2025 Results Analyst and Media Briefing. All participants are in listen-only mode. There will be presentation, followed by a ...

Investors continue to question valuation and wait for stronger earnings momentum. The post Cochlear shares lag the ASX 200 ...

MONTPELLIER, France & SYDNEY--(BUSINESS WIRE)--Regulatory News: Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology, which specializes in the development of novel ...